NO20065807L - Modified release formulation of lithium carbonate and method for the preparation thereof - Google Patents
Modified release formulation of lithium carbonate and method for the preparation thereofInfo
- Publication number
- NO20065807L NO20065807L NO20065807A NO20065807A NO20065807L NO 20065807 L NO20065807 L NO 20065807L NO 20065807 A NO20065807 A NO 20065807A NO 20065807 A NO20065807 A NO 20065807A NO 20065807 L NO20065807 L NO 20065807L
- Authority
- NO
- Norway
- Prior art keywords
- lithium carbonate
- modified release
- preparation
- release formulation
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glanulating (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000783A ITBO20050783A1 (it) | 2005-12-22 | 2005-12-22 | Formulazione a base di litio carbonato a rilascio modificato e metodo per la preparazione della formulazione. |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065807L true NO20065807L (no) | 2007-06-25 |
Family
ID=37963649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065807A NO20065807L (no) | 2005-12-22 | 2006-12-15 | Modified release formulation of lithium carbonate and method for the preparation thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070148253A1 (it) |
EP (1) | EP1803449A2 (it) |
JP (1) | JP2007169277A (it) |
CN (1) | CN101040868A (it) |
CA (1) | CA2571276A1 (it) |
IT (1) | ITBO20050783A1 (it) |
NO (1) | NO20065807L (it) |
ZA (1) | ZA200610466B (it) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100332385A1 (en) * | 2004-08-30 | 2010-12-30 | Randy Mersky | Electronic payment transaction system |
JP4285564B2 (ja) | 2007-06-27 | 2009-06-24 | パナソニック電工株式会社 | 脱毛装置 |
US8641992B2 (en) | 2008-07-18 | 2014-02-04 | Ady Resources Limited | Process for recovering lithium from a brine |
-
2005
- 2005-12-22 IT IT000783A patent/ITBO20050783A1/it unknown
-
2006
- 2006-12-06 EP EP06025211A patent/EP1803449A2/en not_active Withdrawn
- 2006-12-13 ZA ZA200610466A patent/ZA200610466B/en unknown
- 2006-12-14 JP JP2006337433A patent/JP2007169277A/ja active Pending
- 2006-12-15 CA CA002571276A patent/CA2571276A1/en not_active Abandoned
- 2006-12-15 NO NO20065807A patent/NO20065807L/no not_active Application Discontinuation
- 2006-12-19 US US11/612,648 patent/US20070148253A1/en not_active Abandoned
- 2006-12-22 CN CNA2006101699131A patent/CN101040868A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1803449A2 (en) | 2007-07-04 |
CN101040868A (zh) | 2007-09-26 |
US20070148253A1 (en) | 2007-06-28 |
JP2007169277A (ja) | 2007-07-05 |
ZA200610466B (en) | 2008-12-31 |
CA2571276A1 (en) | 2007-06-22 |
ITBO20050783A1 (it) | 2007-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065190L (no) | Farmasoytiske sammensetninger omfattende en amfifil stivelse | |
WO2008049116A3 (en) | Substituted indoles | |
WO2007067044A3 (en) | Modified active-ingredient-containing pellets/capsules | |
WO2008051197A3 (en) | Small-molecule botulinum toxin inhibitors | |
WO2007064885A3 (en) | Oral care compositions, methods, devices and systems | |
WO2008054676A3 (en) | Medical devices and methods of using the same | |
WO2008133938A3 (en) | Targeted integration into the ppp1r12c locus | |
WO2012027065A3 (en) | Combination therapy for treatment of disease | |
WO2006138669A3 (en) | Life-like anatomic feature for testing injection of soft tissue fillers | |
WO2007143204A3 (en) | Compositions and methods for modifying cell surface glycans | |
NO20081042L (no) | PPAR aktive forbindelser | |
WO2006138418A3 (en) | Improvement of cognitive performance with sirtuin activators | |
WO2008053444A3 (en) | Treating a respiratory condition with bifidobacterium | |
WO2005113747A3 (de) | Multizelluläre gewebe- und organkultursysteme | |
EP1841761A4 (en) | Fumagillol derivatives or processes for the preparation of fumagillol derivatives, and pharmaceutical compositions containing them | |
DK2207786T3 (da) | 2´-Fluor-2´-deoxytetrahydrouridiner som cytidindeaminasehæmmere | |
WO2007149406A8 (en) | Modified coagulation factor ix polypeptides and use thereof for treatment | |
NO20082376L (no) | Farmasoytiske sammensetninger | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
NO20073065L (no) | Injiserbare nanopartikulaere olanzapinformuleringer | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
WO2008027600A3 (en) | Imatinib compositions | |
NO20070373L (no) | Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel | |
WO2006002077A3 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |